Orchestra BioMed Statistics
NASDAQ: OBIOHealth Care Medicinal Chemicals and Botanical Products USD
5.63-0.03 (-0.53%)
Market open · Delayed 15 min · as of Oct 8, 10:32 AM ET
Orchestra BioMed by the numbers
Orchestra BioMed has a market capitalization of $338.4 million based on 60.11M shares outstanding. With trailing EPS of $-0.86, Orchestra BioMed is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.8% above its 50-day average and 27.4% above its 200-day average.
Average daily trading volume is 299.24K shares, or about $1.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OBIO valuation vs. peer median
| Metric | OBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $338.39M | $292.43M | +16% |
| Avg. volume | 299.24K | 1.05M | -71% |
Peer median across 8 companies: SNDL, CGC, ACB, USNA, NAGE, GLAS, MDWD, TLRY.
Valuation
- Market cap
- $338.39M
- EPS (TTM)
- $-0.86
- Shares outstanding
- 60.11M
Price and trading
- Previous close
- 5.66
- Open
- 5.64
- Day range
- 5.51 – 5.69
- 52-week range
- 2.78 – 6.50
- 52-week change
- +107.33%
- Beta
- —
- Volume
- 52.83K
- Average volume
- 299.24K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 338.39M
- Forward Pe
- -3.73
- Eps
- -0.86
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.50
- Week52 Low
- 2.78
- Avg Volume
- 299.24K
- Shares Outstanding
- 60.11M
- Ma50
- 5.27
- Ma200
- 4.42
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -13.38%
- Pct From52w Low
- 102.59%